- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Cholangitis, Sclerosing in New Zealand
Total 745 results
-
Mirum Pharmaceuticals, Inc.RecruitingPrimary Biliary Cholangitis | PBCUnited States, United Kingdom, Israel, Germany, Italy, France
-
IpsenActive, not recruitingPrimary Biliary CirrhosisUnited States, France, Spain, Belgium, Germany, Switzerland, Brazil, United Kingdom, Argentina, Canada, Chile, Italy, South Africa, Turkey
-
Cairo UniversityTheodor Bilharz Research Institute; National Hepatology & Tropical Medicine...UnknownCholangitis | Biliary Stricture | Bile Duct Injury | Bile Duct Stricture | Benign Biliary StrictureEgypt
-
Mauna Kea TechnologiesCompletedCholangiocarcinoma | Bile Duct InflammationUnited States, France, Italy
-
Macquarie University, AustraliaKing's College London; Stichting TRICALS FoundationRecruitingAmyotrophic Lateral SclerosisSpain, Australia, United Kingdom, New Zealand, Netherlands, Ireland, Slovenia, Sweden
-
GlaxoSmithKlineRecruitingPruritusUnited States, France, Italy, Japan, Spain, United Kingdom, Bulgaria, Germany, Greece, China, Argentina, Belgium, Brazil, Canada, Czechia, Israel, Mexico, Poland, Russian Federation, Switzerland
-
Icahn School of Medicine at Mount SinaiColumbia University; New York Stem Cell Foundation Research InstituteCompletedClinically Isolated Syndrome | Relapsing-Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
Weill Medical College of Cornell UniversityGenzyme, a Sanofi CompanyCompletedSecondary Progressive Multiple SclerosisUnited States
-
BayerCompletedRelapsing Remitting Multiple Sclerosis (RRMS)China, Slovakia, France, Germany, Korea, Republic of, Saudi Arabia, Singapore, Sweden, Taiwan, Colombia, Czech Republic, Estonia, Italy, Jordan, Lebanon, Mexico, Slovenia, United Kingdom, Argentina, Bahrain, Egypt, United Arab Emirates and more
-
NovartisCompletedClinically Isolated Syndrome | Relapsing Multiple Sclerosis | Relapsing Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
Revalesio CorporationWithdrawnRelapsing Remitting Multiple SclerosisUnited States
-
Icahn School of Medicine at Mount SinaiWithdrawnRelapsing-remitting Multiple Sclerosis (RRMS)United States
-
University of California, Los AngelesUnknownRelapsing-remitting Multiple Sclerosis | Secondary-progressive Multiple Sclerosis | Primary-progressive Multiple SclerosisUnited States
-
Kessler FoundationActive, not recruitingMultiple Sclerosis | Relapsing-remitting Multiple SclerosisUnited States
-
University at BuffaloBiogenCompletedMultiple SclerosisUnited States
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedRelapsing-Remitting Multiple SclerosisUnited States
-
University at BuffaloTeva Pharmaceuticals USACompleted
-
NYU Langone HealthCompleted
-
Bristol-Myers SquibbTerminated
-
Hospital for Special Surgery, New YorkHuman Genome Sciences Inc.CompletedSystemic SclerosisUnited States
-
Hoffmann-La RocheActive, not recruitingRelapsing Multiple Sclerosis | Primary Progressive Multiple SclerosisSpain, United States, Italy, Poland, Turkey, New Zealand, Czechia, Brazil
-
State University of New York at BuffaloCompletedSecondary-progressive Multiple SclerosisUnited States
-
University at BuffaloWithdrawn
-
University at BuffaloCharles University, Czech Republic; General University Hospital, PragueCompletedMultiple Sclerosis, Relapsing-remittingUnited States
-
Genzyme, a Sanofi CompanyCambridge Antibody TechnologyCompletedSystemic Sclerosis | SclerodermaUnited States
-
Hospital for Special Surgery, New YorkGlaxoSmithKlineRecruitingSystemic SclerosisUnited States
-
Regina Elena Cancer InstituteIcahn School of Medicine at Mount Sinai; University of Roma La SapienzaUnknownMultiple Sclerosis | RelapseUnited States, Italy
-
Washington Neuropsychology Research GroupGenzyme, a Sanofi CompanyUnknownRelapsing Remitting Multiple SclerosisUnited States
-
University of Missouri, Kansas CityCompletedRelapsing-remitting Multiple SclerosisUnited States
-
University of Missouri, Kansas CityNational Multiple Sclerosis SocietyCompletedRelapsing-remitting Multiple SclerosisUnited States
-
Columbia UniversityALS AssociationTerminatedAmyotrophic Lateral Sclerosis (ALS)United States
-
NYU Langone HealthCompletedPediatric Multiple SclerosisUnited States
-
University of Medicine and Dentistry of New JerseyCompletedSystemic SclerosisUnited States
-
LAPIX Therapeutics Inc.RecruitingMultiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis, Secondary Progressive | Multiple Sclerosis, Primary ProgressiveUnited States
-
State University of New York at BuffaloGenentech, Inc.Active, not recruitingPrimary Progressive Multiple SclerosisUnited States
-
State University of New York at BuffaloGenentech, Inc.Active, not recruitingPrimary Progressive Multiple SclerosisUnited States
-
Wave Life Sciences Ltd.TerminatedALS | FTDCanada, Belgium, New Zealand, Netherlands, Australia, Sweden, United Kingdom, Ireland
-
Corbus Pharmaceuticals Inc.TerminatedDiffuse Cutaneous Systemic SclerosisUnited States
-
Rutgers, The State University of New JerseyCompletedMultiple SclerosisUnited States
-
Rutgers, The State University of New JerseyCompletedMultiple SclerosisUnited States
-
University of California, Los AngelesJohns Hopkins University; University of Colorado, Denver; Mayo Clinic; University... and other collaboratorsCompletedRelapsing Remitting Multiple SclerosisUnited States, Canada
-
Kessler FoundationInternational Progressive MS AllianceCompletedMemory Impairment | Cognition - Other | Multiple Sclerosis, ProgressiveUnited States
-
City University of New YorkRecruitingMultiple Sclerosis,Gait, ExerciseUnited States
-
Transparency Life SciencesUnknownMultiple Sclerosis, Relapsing-RemittingUnited States
-
Elijah W. StommelBrain Chemistry Labs, Institute for EthnomedicineTerminatedAmyotrophic Lateral Sclerosis (ALS)United States
-
Suhayl Dhib-Jalbut, MDEnrolling by invitation
-
Rutgers, The State University of New JerseyBayerCompletedMultiple SclerosisUnited States
-
Novartis PharmaceuticalsCompletedMayzent (Siponimod) Onboarding of Secondary Progressive Multiple Sclerosis (SPMS) Patients With MSGoSecondary Progressive Multiple SclerosisAustralia
-
Kadmon, a Sanofi CompanyTerminatedDiffuse Cutaneous Systemic SclerosisUnited States
-
Kessler FoundationSt. Barnabas Medical CenterRecruitingMultiple Sclerosis, Relapsing-RemittingUnited States